Global Extracellular Matrix (ECM) Patches Market to Reach $67.3 Million by 2030
The global market for Extracellular Matrix (ECM) Patches estimated at US$33.3 Million in the year 2022, is projected to reach a revised size of US$67.3 Million by 2030, growing at a CAGR of 9.2% over the analysis period 2022-2030. Porcine, one of the segments analyzed in the report, is projected to record 9.7% CAGR and reach US$31.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Bovine segment is readjusted to a revised 9.8% CAGR for the next 8-year period.The U.S. Market is Estimated at $9.1 Million, While China is Forecast to Grow at 14.1% CAGR
The Extracellular Matrix (ECM) Patches market in the U.S. is estimated at US$9.1 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$16.1 Million by the year 2030 trailing a CAGR of 14.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 8.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.Select Competitors (Total 42 Featured) -
- Admedus Ltd.
- Aziyo Biologics
- Baxter
- Boston Scientific Corporation
- Coloplast Group
- Cook Group
- DSM
- Koninklijke Dsm N.V.
- Medtronic
- Mtf Biologics
- Smith & Nephew
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Admedus Ltd.
- Aziyo Biologics
- Baxter
- Boston Scientific Corporation
- Coloplast Group
- Cook Group
- DSM
- Koninklijke Dsm N.V.
- Medtronic
- Mtf Biologics
- Smith & Nephew
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 93 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 33.3 Million |
Forecasted Market Value ( USD | $ 67.3 Million |
Compound Annual Growth Rate | 9.2% |
Regions Covered | Global |